Home | Welcome to Contract Pharma   
Last Updated Thursday, July 31 2014
Print

Breaking News

Related Searches:
November 3, 2010
Toxikon Corp. has completed toxicity studies in two species for Cellceutix Corp.’s Kevetrin, a compound in development for the treatment of resistant lung and breast cancers.  Read More »
November 2, 2010
Revenues in the quarter were boosted by $5.2 billion, or 44%, due to legacy Wyeth products, and negatively impacted by $458 million, or 4%, due to legacy Pfizer products, including the loss of exclusivity of Lipitor in Canada and Spain, as well as Camptos  Read More »
November 2, 2010
SGS has acquired M-Scan, a group of chemical analysis labs that provides advanced chemical and biochemical testing, GLP/GMP contract analytical services, and consultancy and training based on mass spectrometry and chromatography.  Read More »
November 2, 2010
Donald B. Rice, Ph.D. will retire from Agensys, Inc., an affiliate of Astellas Pharma, Inc.  Read More »
November 2, 2010
Clinical Research Services (CRS) revenue was $231.6 million in the quarter (+14%).  Read More »
November 2, 2010
Quintiles and Dako, a provider of tissue-based cancer diagnostics, have entered a strategic alliance to advance personalized medicine through the development of targeted therapies and companion diagnostics.  Read More »
November 1, 2010
Total specialty pharmaceuticals sales were up 5% in the quarter and medical devices sales increased 8%.   Read More »
November 1, 2010
Valeant Pharmaceuticals and Kadmon Pharmaceuticals have entered two strategic agreements for the development and commercialization of taribavirin and the marketing of ribavirin in the treatment of viral diseases.  Read More »
November 1, 2010
Ludo Reynders, Ph.D. has been appointed chief executive officer of Premier Research Group Ltd.   Read More »
October 29, 2010
Atwood to coordinate global sales  Read More »
October 29, 2010
SA builds up position in $15 billion market  Read More »
October 29, 2010
Top 10 pharma to use CTM simulator/optimizer  Read More »
October 29, 2010
SP integration continues, and a $1 billion reserve hedges another Vioxx settlement  Read More »
October 28, 2010
Generics hurt pharma revenues in U.S.  Read More »
October 28, 2010
Generics, lack of flu pandemic lead to 13% drop in U.S. sales  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On